Roger Conrad

Analyst Articles

  • April 9, 2007

In May of 2005, during the annual meeting of the Asian Development Bank, finance ministers from thirteen Asian nations moved a step closer to creating an Asian monetary fund and establishing a Silk Road for a new era. Although building this road is a long process, the fact is Asian countries (including Japan) are pushing for more regional financial integration. Read More

  • April 6, 2007

DWS Multi-Market (NYSE: KMM) has issued rights offerings to all shareholders, giving them the right to purchase new shares at net asset value or 95 percent of the prevailing market price of the fund's shares. Read More

Updated April 6, 2007. Editor’s Note: Earnings News should be read in conjunction with the How They Rate article. For more numbers and current trading advice, see the How They Rate Table. Oil & Gas Advantage Energy Income Fund (AVN.UN, NYSE: AAV) reported net income for the fourth quarter declined 66 percent to CD8.7… Read More

  • April 4, 2007

The Energy Strategist model Portfolios are off to a solid start for 2007. The income-oriented Proven Reserves Portfolio rallied more than 9 percent in the first quarter, buoyed by a solid showing for several of my recommended master limited partnership (MLP) recommendations. Read More

  • April 4, 2007

It’s becoming increasingly obvious that the majority of investors remain uncertain as to what will be the final outcome of the Federal Reserve’s moves and the slowdown of the US economy this year. The debate between deflationists and inflationists remains animated.   Read More

  • April 4, 2007

Global drug delivery company, pSivida Limited, announced today that it has signed US$165m exclusive worldwide Collaborative Research and Licensing Agreement with Pfizer Inc. for pSivida's controlled drug delivery technologies including the Medidur technology in ophthalmic applications. Read More

  • April 4, 2007

We’re continuing to buy into our nanotechnology and nano-materials company for many of the same reasons that we’ve been buying into pSivida. It won’t be Altairnano that makes the massive long-term profits from its developments, but some big, well-established corporation. Read More